Bone Disease
15
1
1
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.7%
1 terminated out of 15 trials
90.9%
+4.4% vs benchmark
20%
3 trials in Phase 3/4
30%
3 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (15)
Safety And Tolerability Study Of RN564 In Women With Osteopenia And Healthy Men.
Deep Phenotyping of Bone Disease in Type 2 Diabetes and Relations to Diabetic Neuropathy
Vitamin D Supplementation in Diabetic Nephropathy
Effect of Vitamin K2 (MK7) on Cardiovascular and Bone Disease in Dialysis Patients
Prospective Biomarkers of Bone Metabolism in Hemophilia A
Bone Architectural Parameters in Postmenopausal Women Affected With Primary Hyperparathyroidism
Influence of Nitrates on Bone Remodeling and Endothelial Function in Patients With Type 2 Diabetes Mellitus
Effect of Vitamin D3 Supplementation on Cardiometabolic Risk
Non-interventional Substudy of ALX-HPP-502 to Assess Natural History of Patients With Juvenile-onset HPP Who Served as Historical Controls in ENB-006-09
Calcium Phosphate Cement Registry (CPC Registry)
Bone Regeneration Using Bone Marrow Stromal Cells
A Clinical Investigation of the M2a-Magnum™ Hip System
Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort
European Transplant Registry of Senior Renal Transplant Recipients on Advagraf
Metabolic Acidosis in Renal Transplant Patients